Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan-Mar;11(1):24-28.
doi: 10.4103/jhrs.JHRS_55_17.

Effectiveness of Anti-Mullerian Hormone-tailored Protocol Compared to Conventional Protocol in Women Undergoing In vitro Fertilization: A Randomized Controlled Trial

Sumi Thomas  1 , Mousumi Acharya  1 , K Muthukumar  1 , Achamma Chandy  1 , Mohan S Kamath  1 , T K Aleyamma  1
Affiliations

Effectiveness of Anti-Mullerian Hormone-tailored Protocol Compared to Conventional Protocol in Women Undergoing In vitro Fertilization: A Randomized Controlled Trial

Sumi Thomas et al. J Hum Reprod Sci. 2018 Jan-Mar.

Abstract

Background: Assessment of ovarian reserve before an in vitro fertilization cycle (IVF) is one among the many factors that predicts a successful cycle. Individualized protocol based on ovarian reserve is designed to optimize the pregnancy outcome without compromising the patient safety. Although authors have shown that anti-Mullerian hormone-tailored (AMH) protocols have reduced the treatment burden and improved pregnancy rates, a few others have questioned its efficacy.

Aims: The aim of this study was to decide whether the AMH-tailored protocol or the conventional protocol better decides IVF outcomes.

Setting and design: Prospective randomized controlled trial conducted at a tertiary level university hospital.

Materials and methods: Patients undergoing theirfirst IVF cycle who fulfilled the inclusion criteria were recruited and randomized to each group. Serum follicle-stimulating hormone was done for the patients on day 2 or 3 of a prior menstrual cycle, and serum AMH was done in the preceding cycle.

Statistical analysis: Analysis was performed using SPSS software version 16.

Results and conclusion: There were 100 patients in each group. A total of 83 patients underwent embryo transfer in the conventional group and 78 patients in the AMH group. The clinical pregnancy rates per initiated cycle (36.4% vs. 33.3%) and per embryo transfer (45.1% vs. 41.3%) were similar in both the groups. There was no statistical difference in the number of cycles cancelled due to poor response or the risk of ovarian hyperstimulation syndrome in both the groups. Hence, this study showed the similar effectiveness of AMH-tailored protocol and conventional protocol in women undergoing IVF.

Keywords: Anti-Mullerian hormone; follicle stimulating hormone; in vitro fertilization.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart
See this image and copyright information in PMC

References

    1. Verberg MF, Eijkemans MJ, Heijnen EM, Broekmans FJ, de Klerk C, Fauser BC, et al. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod. 2008;23:2050–5. - PubMed
    1. Lintsen AM, Eijkemans MJ, Hunault CC, Bouwmans CA, Hakkaart L, Habbema JD, et al. Predicting ongoing pregnancy chances after IVF and ICSI: A national prospective study. Hum Reprod. 2007;22:2455–62. - PubMed
    1. Nelson SM, Anderson RA, Broekmans FJ, Raine-Fenning N, Fleming R, laMarca A. Anti-mullerian hormone: Clairvoyance or crystal clear? Hum Re-prod. 2012;27:631–6. - PubMed
    1. Nelson SM, La Marca A. The journey from the old to the new AMH assay: How to avoid getting lost in the values. Reprod Biomed Online. 2011;23:411–20. - PubMed
    1. FSH Treatment Guidelines Clinical Panel. Howles CM, Saunders H, Alam V, Engrand P. Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alpha) during assisted reproductive technology(ART) procedures. An analysis of 1378 patients. Curr Med Res Opin. 2006;22:907–18. - PubMed

LinkOut - more resources